en

PRODUCT DETAIL

ZAHRON 15 mg

Code 4064C
MA number 31/0150/17-S
Product Form: tbl flm 10x15 mg (blis.PA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10A Lipid modifying agents, plain
C10AA HMG CoA reductase inhibitors
C10AA07 Rosuvastatin
Shelf life: 24
Container: blister PA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 30.05.2017
Validity: 30.05.2022
MA renewed: Renewal application submitted
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_ZAHRON 15 mg_30 mg_05.2022.pdf  
SPC: SPC_ZAHRON 15 mg_30 mg_05.2022.pdf  
Safety feature Yes
Data update: 06.12.2018
eu-flag.png sk-flag.png